Jung, D., Yun, M., Kim, E., Kim, J., Kim, B., Jung, J. H., . . . Kim, S. (2014). The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine. Oncotarget.
Stile di citazione ChicagoJung, Deok-Beom, et al. "The Heparan Sulfate Mimetic PG545 Interferes With Wnt/β-catenin Signaling and Significantly Suppresses Pancreatic Tumorigenesis Alone and in Combination With Gemcitabine." Oncotarget 2014.
Citazione MLAJung, Deok-Beom, et al. "The Heparan Sulfate Mimetic PG545 Interferes With Wnt/β-catenin Signaling and Significantly Suppresses Pancreatic Tumorigenesis Alone and in Combination With Gemcitabine." Oncotarget 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.